Related Experiment Video
Updated: Mar 22, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
SMOC Binds to Pro-EGF, but Does Not Induce Erk Phosphorylation via the EGFR
J Terrig Thomas1, Lina Chhuy-Hy1, Kristin R Andrykovich1
1FDA/Center for Biologics Evaluation and Research, Division of Cellular and Gene Therapies Office of Cellular, Tissue, and Gene Therapies, Silver Spring, MD, United States of America.
Abstract:
In an attempt to identify the cell-associated protein(s) through which SMOC (Secreted Modular Calcium binding protein) induces mitogen-activated protein kinase (MAPK) signaling, the epidermal growth factor receptor (EGFR) became a candidate. However, although in 32D/EGFR cells, the EGFR was phosphorylated in the presence of a commercially available human SMOC-1 (hSMOC-1), only minimal phosphorylation was observed in the presence of Xenopus SMOC-1 (XSMOC-1) or human SMOC-2. Analysis of the commercial hSMOC-1 product demonstrated the presence of pro-EGF as an impurity. When the pro-EGF was removed, only minimal EGFR activation was observed, indicating that SMOC does not signal primarily through EGFR and its receptor remains unidentified. Investigation of SMOC/pro-EGF binding affinity revealed a strong interaction that does not require the C-terminal extracellular calcium-binding (EC) domain of SMOC or the EGF domain of pro-EGF. SMOC does not appear to potentiate or inhibit MAPK signaling in response to pro-EGF, but the interaction could provide a mechanism for retaining soluble pro-EGF at the cell surface.
Insights
Secreted Modular Calcium binding protein (SMOC) does not primarily signal through the epidermal growth factor receptor (EGFR). Researchers found SMOC binds to pro-Epidermal Growth Factor (pro-EGF), potentially retaining it on cell surfaces.
Area of Science:
- Cell signaling
- Molecular biology
- Protein interactions
Background:
- Secreted Modular Calcium binding protein (SMOC) is implicated in mitogen-activated protein kinase (MAPK) signaling.
- The epidermal growth factor receptor (EGFR) was investigated as a potential mediator of SMOC-induced signaling.
Purpose of the Study:
- To identify the cell-associated protein responsible for SMOC-induced MAPK signaling.
- To investigate the interaction between SMOC and pro-Epidermal Growth Factor (pro-EGF).
Main Methods:
- Phosphorylation assays in 32D/EGFR cells using various SMOC proteins.
- Analysis of commercial SMOC-1 for impurities.
- Binding affinity studies between SMOC and pro-EGF.
Main Results:
- Commercial human SMOC-1 (hSMOC-1) induced EGFR phosphorylation, but this was attributed to a pro-Epidermal Growth Factor (pro-EGF) impurity.
- Xenopus SMOC-1 (XSMOC-1) and human SMOC-2 showed minimal EGFR activation.
- SMOC exhibited strong binding to pro-EGF, independent of specific domains.
- SMOC did not significantly alter pro-EGF's effect on MAPK signaling.
Conclusions:
- SMOC does not primarily signal through EGFR; its specific receptor remains unidentified.
- SMOC interacts with pro-EGF, potentially regulating its cell surface localization.
- This interaction may influence pro-EGF availability without directly modulating MAPK signaling pathways.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Mitogens and the Cell Cycle
MAPK Signaling Cascades
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Amplifying Signals via Enzymatic Cascade

